Resistance of human squamous carcinoma cells to transforming growth factor beta 1 is a recessive trait

scientific article

Resistance of human squamous carcinoma cells to transforming growth factor beta 1 is a recessive trait is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode1993PNAS...90.6280R
P356DOI10.1073/PNAS.90.13.6280
P932PMC publication ID46912
P698PubMed publication ID8327510
P5875ResearchGate publication ID14870810

P50authorMichael ReissQ56547220
P2093author name stringJ M Cowan
Z L Zhou
T Muñoz-Antonia
P C Wilkins
V F Vellucci
P2860cites workTGF beta signals through a heteromeric protein kinase receptor complexQ24337608
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform ExtractionQ25938986
Identification of a chromosome 18q gene that is altered in colorectal cancersQ28274172
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Q29547773
The transforming growth factor-beta familyQ29615948
Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transferQ34538564
mRNA phenotyping by enzymatic amplification of randomly primed cDNA.Q36073108
Transforming growth factor-beta: possible roles in carcinogenesisQ36465897
Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA.Q36886337
Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1Q36920336
Escape from transforming growth factor beta control and oncogene cooperation in skin tumor developmentQ37611617
Analysis of genes and chromosomes by nonisotopic in situ hybridizationQ37740240
Chapter 18 Induction of Mammalian Somatic Cell Hybridization by Polyethylene GlycolQ39152538
Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybridsQ41083849
Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomasQ41117144
Mutant p53 tumor suppressor gene causes resistance to transforming growth factor beta 1 in murine keratinocytesQ41573537
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinaseQ41639273
Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemiasQ41643691
Induction and autocrine receptor binding of transforming growth factor-beta 2 during terminal differentiation of primary mouse keratinocytesQ42479606
Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndromeQ42602478
Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free mediumQ45345222
A new human cell line (FaDu) from a hypopharyngeal carcinoma.Q52829962
High frequency of resistance of human squamous carcinoma cells to the anti-proliferative action of transforming growth factor beta.Q53510902
Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA.Q54378341
Drug-resistant mutants: selection and dominance analysis.Q54415860
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorshipQ57338704
Status of the p53 tumor suppressor gene in human squamous carcinoma cell linesQ67991606
Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal growth factorQ69009790
Growth modulation of mouse keratinocytes by transforming growth factorsQ69019850
Reinitiation of DNA synthesis in quiescent mouse keratinocytes; regulation by polypeptide hormones, cholera toxin, dexamethasone, and retinoic acidQ69032172
Modulation of the mitogenic response of an epidermal growth factor-dependent keratinocyte cell line by dexamethasone, insulin, and transforming growth factor-betaQ69036524
Phenotype of low proliferative potential is dominant in hybrids of normal human fibroblastsQ70572057
P433issue13
P407language of work or nameEnglishQ1860
P1104number of pages5
P304page(s)6280-6284
P577publication date1993-07-01
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleResistance of human squamous carcinoma cells to transforming growth factor beta 1 is a recessive trait
P478volume90

Reverse relations

cites work (P2860)
Q33888325Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents
Q37227206Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.
Q73969923Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7
Q54127845Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion.
Q33957851Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency
Q33834888Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.
Q24681272Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II
Q35782377Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic.
Q27824786SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
Q42519294TGF beta promotes the basal phenotype of epidermal keratinocytes: transcriptional induction of K#5 and K#14 keratin genes
Q41442972Transforming growth factor-beta and prostate cancer.

Search more.